950160 — Kolon TissueGene Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapMomentum Trap

Annual balance sheet for Kolon TissueGene, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	90.8	51.8	32.9	46	21.3
Net Total Accounts Receivable
Net Total Receivables	3.11	0.679	0.289	0.582	1.07
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	96	57.9	36.7	49.8	24.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	9.29	8.39	7.55	6.44	5.48
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	107	66.9	51.8	86.7	105
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13	14	13.6	9.16	11.1
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	27.6	22.7	19.2	14.5	15.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	79.6	44.2	32.6	72.2	89.2
Total Liabilities & Shareholders' Equity	107	66.9	51.8	86.7	105
Total Common Shares Outstanding
Total Preferred Shares Outstanding